每经AI快讯，中红医疗（SZ 300981，收盘价：15.42元）12月9日晚间发布公告称，公司第四届第十五 次董事会会议于2025年12月8日以通讯方式召开。会议审议了《关于召开2025年第四次临时股东会的议 案》等文件。 2025年1至6月份，中红医疗的营业收入构成为：医疗器械行业占比100.0%。 截至发稿，中红医疗市值为66亿元。 每经头条（nbdtoutiao）——处方药变"瘾品"：国内首次报告普瑞巴林滥用致成瘾病例，网络平台暴 露"无病历可购药"漏洞，列管与否尚需科学考量 （记者 曾健辉） ...

证券代码：300981 证券简称：中红医疗 公告编号：2025-107 中红普林医疗用品股份有限公司 关于子公司参与集中带量采购项目拟中选的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 中红普林医疗用品股份有限公司（以下简称"公司"）控股子公司江西科伦 医疗器械制造有限公司（以下简称"科伦医械"）于近期参加江西省医用耗材带 量价格联动采购项目的投标工作。根据江西省医用耗材带量价格联动第一批带量 联动品种拟中选清单和采购需求量的公示结果显示，科伦医械部分产品拟中选上 述集中带量采购项目。现将相关情况公告如下： 品种分类 耗材型号规格 产品及注册证号 注册分类 适用范围 拟中选价 格及数量 拟供应 地区 一次性使 用输液用 肝素帽 HP-1 一次性使用输液用 肝素帽 国械注准 20163141530 Ⅲ类 本产品适用与静脉留 置针配合使用，为输 液 提 供 通 道 和 注 射 口。 中选数量 不对外公 开，中标价 格1.2元/ 个 江西省 一、拟中选产品基本情况 远发展产生积极影响。 三、风险提示 本次拟中选产品相关采购合同尚未签订，后续事项及对公司的影响 ...

中红普林医疗用品股份有限公司 关于公司及子公司2026年度向银行申请综合授信额度暨公 司为子公司申请综合授信额度提供担保的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、授信及担保情况概述 中红普林医疗用品股份有限公司（以下简称"公司"）于 2025 年 12 月 8 日召开第四届董事会第十五次会议，审议通过了《关于公司及子公司 2026 年度 向银行申请综合授信额度暨公司为子公司申请综合授信额度提供担保的议案》， 同意公司及控股子公司（包括 2026 年度新增的控股子公司）2026 年度向相关银 行申请综合授信额度合计不超过 50 亿元，最终以各家银行实际审批的授信额度 为准，其中以自有资产抵质押等方式向上述金融机构申请授信额度总额不超过人 民币 10 亿元，各抵质押主体可在总抵质押额度范围内使用；并同意公司为控股 子公司 2026 年度向金融机构申请的授信额度提供担保，担保额度总计不超过 25 亿元，其中，为资产负债率 70%（含）以上的控股子公司提供担保额度为不超过 15 亿元。 为便于实施上述向银行申请授信及担保事项，公司董事会提请股东会授权 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 中红普林医疗用品股份有限公司（以下简称"公司"）第四届董事会第十 五次会议拟定于 2025 年 12 月 25 日（星期四）召开 2025 年第四次临时股东会， 会议有关事项通知如下： 一、召开会议的基本情况 1、股东会届次：2025年第四次临时股东会 证券代码：300981 证券简称：中红医疗 公告编号：2025-106 中红普林医疗用品股份有限公司 关于召开 2025 年第四次临时股东会的通知 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第2号—创业 板上市公司规范运作》等法律、行政法规、部门规章、规范性文件及《公司章 程》的有关规定。 2、股东会的召集人：董事会 4、会议时间： （1）现场会议时间：2025年12月25日14:30 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025年12月25日9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所 互联网投票系统投票的具 ...

一、会议召开情况 中红普林医疗用品股份有限公司（以下简称"公司"）第四届董事会第十五 次会议于 2025 年 12 月 8 日以通讯方式召开，2025 年 12 月 3 日公司以电话和电 子邮件方式向全体董事发出会议通知。会议应出席董事 9 人，实际出席董事 9 人。会议由董事长桑树军先生主持，公司高级管理人员和相关人员列席了会议。 会议的召集、召开符合相关法律、法规和《公司章程》的规定。 证券代码：300981 证券简称：中红医疗 公告编号：2025-104 中红普林医疗用品股份有限公司 第四届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 二、会议审议情况 1.审议通过《关于公司及子公司 2026 年度向银行申请综合授信额度暨公司 为子公司申请综合授信额度提供担保的议案》 同意公司及控股子公司（包括 2026 年度新增的控股子公司）2026 年度向相 关银行申请综合授信额度合计不超过 50 亿元，最终以各家银行实际审批的授信 额度为准，其中以自有资产抵质押等方式向上述金融机构申请授信额度总额不超 过人民币 10 亿元，各抵质押主 ...

Core Viewpoint - Zhonghong Medical (300981) has shown a mixed performance in terms of stock price and financial metrics, with a notable decline in net profit and revenue in recent quarters, indicating potential challenges in the medical device industry [1][5]. Financial Performance - As of December 4, 2025, Zhonghong Medical's stock closed at 15.21 yuan, up 3.82%, with a trading volume of 190,200 shares and a total transaction value of 283 million yuan [1]. - For the first three quarters of 2025, the company reported a main revenue of 1.864 billion yuan, a year-on-year increase of 1.38%, but a net profit of -7.21 million yuan, a year-on-year decrease of 114.13% [5]. - The third quarter alone saw a revenue of 626 million yuan, down 9.24% year-on-year, and a net profit of -12.95 million yuan, down 170.01% year-on-year [5]. Financing and Capital Flow - On December 4, 2025, the net outflow of main funds was 15.82 million yuan, accounting for 5.59% of the total transaction value, while retail investors saw a net inflow of 3.77 million yuan, representing 1.33% of the total [1]. - In the financing and securities lending segment, the company had a net financing purchase of 500,100 yuan on the same day, with a cumulative net purchase of 12.19 million yuan over the last three days [2]. Industry Comparison - Zhonghong Medical's total market value is 6.523 billion yuan, which is below the industry average of 10.958 billion yuan, ranking 54 out of 124 in the medical device sector [3]. - The company's net asset value stands at 5.508 billion yuan, above the industry average of 3.893 billion yuan, ranking 25 out of 124 [3]. - The gross profit margin is reported at 10.54%, significantly lower than the industry average of 51.22%, ranking 123 out of 124 [3].

Group 1 - The A-share market indices have shown an upward trend, with the Shanghai Composite Index rising by 0.02%, the Shenzhen Component Index by 0.24%, and the ChiNext Index by 0.64% as of December 4, 2025 [1] - The Medical Device ETF (562600) increased by 0.11%, with the latest price at 0.873 yuan and an intraday turnover rate of 0.58% [1] - Among the constituent stocks, Yirui Technology led with a gain of 3.94%, while Xiangyu Medical experienced the largest decline at 2.78% [1] Group 2 - Long-term demand for medical devices is driven by the relentless pursuit of health and life, indicating that the industry lacks significant cyclicality but may experience short-term fluctuations due to external factors [2] - The medical device industry in China is projected to grow from 1.20 trillion yuan in 2024 to 2.11 trillion yuan by 2030, with an average annual growth rate of 9.85%, driven by aging populations, chronic disease prevalence, and innovations in the industry [2] - By 2026, the industry is expected to see a "moderate recovery" in fundamentals, supported by improving demand, innovation, and policy enhancements, although risks related to demand recovery and cost control policies remain [2]

Core Viewpoint - The flu virus is becoming increasingly active in China as the autumn and winter temperatures drop, with the positive rate of flu-like cases nearing 45%, indicating a significant rise in respiratory infectious diseases [1] Group 1: Flu Activity and Prevention - The flu virus can spread through droplets and contact with contaminated surfaces, emphasizing the need for effective protective measures [1] - The Chinese Center for Disease Control and Prevention highlights the importance of hand protection in preventing the transmission of the flu virus [1] Group 2: Company Overview - Zhonghong Medical, a state-controlled listed company, is a leading player in the domestic medical protection sector, offering a comprehensive range of medical gloves to enhance health protection during the flu season [1][2] - The company provides various types of disposable protective gloves, including medical examination gloves and household protective gloves, catering to different scenarios from professional medical use to home care [2] Group 3: Product Features and Innovations - Zhonghong Medical's gloves are designed to meet industry standards and utilize innovative materials and processes to create a multi-layered hand protection system for flu prevention [2] - The company emphasizes the importance of proper glove usage, including the "one-use-one-change" principle, to minimize the risk of secondary contamination [2] Group 4: Future Focus and Product Expansion - In addition to disposable health protection gloves, Zhonghong Medical is expanding its product line to include condoms, safety infusion devices, wireless monitoring sensors, and other health-related products [2] - The company plans to focus on developing life support devices, surgical instruments, implantable devices, and assisted reproductive technology products in the future [2]

Group 1 - The core viewpoint of the article is that Zhonghong Medical (300981) is committed to leveraging its business and industry advantages while focusing on the healthcare sector [1] Group 2 - The actual controller of the company is the Xiamen State-owned Assets Supervision and Administration Commission [1] - The company is actively engaging with investors through interactive platforms to address inquiries [1]

Group 1 - The core viewpoint of the article highlights the role of Zhonghong Medical as a state-owned enterprise in Fujian, emphasizing its commitment to leveraging its business and industry advantages in the healthcare sector [1] - Zhonghong Medical is under the actual control of the Xiamen State-owned Assets Supervision and Administration Commission, which indicates strong governmental support [1] - The company expresses gratitude for investor interest and reiterates its focus on the medical and health industry [1]